ENCAB000AFR
Antibody against Homo sapiens CTCF
Homo sapiens
K562, GM12878, HeLa-S3
not characterized to standards
- Status
- released
- Source (vendor)
- Santa Cruz Biotech
- Product ID
- sc-5916
- Lot ID
- K0902
- Characterized targets
- CTCF (Homo sapiens)
- Host
- goat
- Clonality
- polyclonal
- Isotype
- IgG
- Antigen description
- Epitope mapping at the N-terminus of CTCF of human origin.
- External resources
Characterizations
CTCF (Homo sapiens)
K562GM12878HeLa-S3
compliant
- Caption
- Whole cell lysate or nuclear extract were immunoprecipitated using primary antibody.The IP fraction was separated on a 12% acrylamide gel with the Bio-Rad PROTEAN II xi system.After separation, the samples were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.The membrane was probed with primary antibody (same as that used for IP) and a secondary HRP-conjugated antibody.The resulting bands were visualized with SuperSignal West Femto solution (Thermo Scienfiic). Results & Figure legend: IP-western with sc-5916 anti-CTCF antibody in nuclear extract (NE) of K562 and whole cell lysate (WCL) of K562, GM12878, and HeLa cells.Protein marker (PM) labeled in kDa.A band of expected size for CTCF (~120 kDa) was detected, representing the strongest signal, except for heavy chain contamination.
- Submitter comment
- no IgG control
- Submitted by
- Flo Pauli-Behn
- Lab
- Richard Myers, HAIB
- Grant
- U54HG006998
CTCF (Homo sapiens)
not compliant
- Caption
- ChIP-seq was performed with an antibody (Active Motif, 39852) that targets a different part of the CTCF protein in two replicates of K562 cells.CTCF occupancy sites were identified with the MACS peak caller.These sites were compared with IDR (Landt et al. 2012, Li et al. 2012, https://sites.google.com/site/anshulkundaje/projects/idr) to the CTCF occupancy sites that were previously identified in two replicates of K562 cells using the sc-5916 antibody. Results:IDR results of ChIP comparison by IDR between two K562 biological replicates of ChIP with CTCF (sc-5916) and CTCF (AM 61312).All of the Np/Nt ratios are less than 2, indicating significant replication of binding sites when ChIP is perfomed with the two antibodies directed against CTCF.
- Reviewer comment
- The comparison ChIP data is not submitted nor is the antibody characaterized
- Submitted by
- Flo Pauli-Behn
- Lab
- Richard Myers, HAIB
- Grant
- U54HG006998